Cargando…
Denosumab is Effective for Controlling Serum Calcium Levels in Patients with Humoral Hypercalcemia of Malignancy Syndrome: A Case Report on Parathyroid Hormone-related Protein-producing Cholangiocarcinoma
Hypercalcemia resulting in the elevation of serum parathyroid hormone-related protein (PTHrP) and suppression of serum PTH was observed in a patient with advanced cholangiocarcinoma (CCC) and multiple lymph node metastases. We confirmed humoral hypercalcemia of malignancy based on PTHrP-producing CC...
Autores principales: | Ashihara, Norihiro, Nakajima, Koji, Nakamura, Yoshiyuki, Kobayashi, Mutsuhiro, Shirahata, Kumiko, Maeda, Chika, Uehara, Takeshi, Gomi, Daisuke, Ito, Nobuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216142/ https://www.ncbi.nlm.nih.gov/pubmed/27904108 |
Ejemplares similares
-
Humoral Hypercalcemia of Malignancy with a Parathyroid Hormone-Related Peptide-Secreting Intrahepatic Cholangiocarcinoma Accompanied by a Gastric Cancer
por: Takeda, Katsushi, et al.
Publicado: (2017) -
Humoral Hypercalcemia in a Patient with Cholangiocellular Carcinoma – Effective Therapy with Denosumab
por: Harsch, Igor Alexander, et al.
Publicado: (2019) -
Denosumab for the Treatment of Hypercalcemia in a Patient With Parathyroid Carcinoma: A Case Report
por: Roukain, Abdallah, et al.
Publicado: (2022) -
Successful Control of Hypercalcemia with Sorafenib, Evocalcet, and Denosumab Combination Therapy for Recurrent Parathyroid Carcinoma
por: Makino, Hirofumi, et al.
Publicado: (2022) -
Two Cases of Humoral Hypercalcemia of Malignancy in Metastatic Cholangiocarcinoma
por: Lim, Seungtaek, et al.
Publicado: (2013)